Novo Nordisk, maker of Ozempic, accuses rival Eli Lilly of false advertising0

• Gear / Gear News and Events, General, News, Newsletters, Security / Security News
• July 21, 2026

The lawsuit comes as pharmaceutical heavyweights Novo and Eli Lilly are locked in a battle to dominate the fast-growing weight-loss drug industry, especially in the United States, which analysts have estimated could be worth more than $100 billion by 2030. Novo Nordisk claimed that its main competitor in the weight-loss drug business had committed “multiple